HWN Suggests

Understanding Opioid Antagonists: What They Are and How They Work

Opioid antagonists like naloxone and naltrexone represent powerful tools in combating the opioid crisis, swiftly reversing overdoses and blocking euphoric effects to disrupt addiction cycles. By binding to opioid receptors without activating them, these agents restore normal brain function, pave the way for detoxification, and support sustained recovery when integrated into comprehensive treatment protocols. As research advances novel formulations and delivery methods, their accessibility continues to grow, offering hope to millions while expanding options for individualized care, improving treatment retention, and strengthening community-based strategies aimed at preventing overdose deaths and…

read full article

Featured

 Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?

Nature gave man opioid agonists and scientists have created antagonists to combat them. Which will prove the most powerful in the end? These antagonists sure are providing an interesting subplot to the battle against opioid agonists. Sometimes in medicine it is hard to determine what characteristics describe the antagonist hero (naloxone) and that of the protagonist villain (Opioids)? Is the hero (naloxone) really going to protect humanity from a powerful enemy (Opioids)? Is pain no longer the evil bad guy? Are the prescribers, pharmacists and drug pushers the enemies now? Are patients really just non-competitors in this scenario and unable to stay out of “harm’s way” or utilize powerful pain management treatments safely due to unmanageable side effects or life-threatening dangers? We will see!

Articles of Interest

Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds

Black patients with opioid use disorder were far less likely to fill prescriptions for the most effective addiction treatments than white patients. But strikingly few patients of all races got the medicine.

Are opioid antagonists effective in reducing self-injury in adults with intellectual disability? A systematic review

This review suggests that some people respond to opioid antagonists with a reduction in self-injury but the trials do not predict who they may be. Future research may identify this sub-group when opioid antagonists may prove to be a useful addition in the pharmacotherapy of self-injury.

Naloxone Man: The IRL Superhero Teaching People How to Reverse Overdoses

Naloxone – known by its brand name Narcan in the US, where it typically comes in a nasal spray – is a competitive opioid antagonist used to temporarily reverse overdose from opiates like heroin. It’s been used in clinical settings and by paramedics for years, but is increasingly given directly to police officers and the general public to quickly treat those at risk of death.

Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases

Naltrexone is an oral-activated opioid antagonist with biphasic dose-dependent pharmacodynamic effects. The molecule acts as a competitive inhibitor of opioid receptors at high doses. However, naltrexone at low doses has been shown to have hormetic effects and provides relief for chronic pain conditions such as fibromyalgia, multiple sclerosis (MS), and inflammatory bowel disorders.

Opioid Agonists, Partial Agonists, Antagonists: Oh My!

Finally, like in every great story, there are antagonists. However, in the story of opioids, opioid antagonists may save lives. Naltrexone is an opioid antagonist that blocks the effects of opioids by competitive binding. Naltrexone is indicated for alcohol and opioid dependence and useful because its opioid receptor blockade secondarily diminishes dopamine activity that is otherwise enhanced by alcohol.29 Naloxone is a mu-opioid receptor antagonist and reversal agent used to mitigate risk for opioid-induced respiratory depression by displacing the full opioid agonists.

Opioid Antagonist

Opioid antagonists are defined as substances that block opioid receptors, thereby inhibiting the effects of opioids. They can be peripherally restricted, selectively targeting opioid receptors outside the central nervous system, as exemplified by drugs like methylnaltrexone and alvimopan.

Opioid Antagonists

Opioid receptor antagonists block one or more of the opioid receptors in the central or peripheral nervous system. Opioid receptors are specific transmembrane neurotransmitter receptors that couple G-proteins, which upon stimulation by endogenous or exogenous opioids, lead to the intracellular process of signal transduction. The two most commonly used centrally acting opioid receptor antagonists are naloxone and naltrexone.

Opioid antagonists for smoking cessation

Opioid antagonists are a type of drug which blunts the effects of narcotics such as heroin and morphine, and might help reduce nicotine addiction by blocking some of the rewarding effects of smoking. Our review identified eight trials of naltrexone, a long-acting opioid antagonist. The trials included over 1200 smokers. Half the trials gave everyone nicotine replacement therapy and tested whether naltrexone had any additional benefit. Compared to a placebo, naltrexone did not increase the proportion of people who had stopped smoking, at the end of treatment, or at six months or more after treatment, either on its own or added to NRT. The available evidence does not suggest that opioid antagonists such as naltrexone assist smoking cessation.

Opioid Antagonists: A Review of Their Role in Palliative Care, Focusing on Use in Opioid-Related Constipation

Opioid antagonists have well-established indications in the reversal of life-threatening opioid toxicity, but also hold considerable promise for other applications in palliative care practice, particularly management of opioid-related constipation. We briefly review current understanding of opioid receptors, focusing on their complex role in gastrointestinal physiology.

Opioid antagonists: clinical utility, pharmacology, safety, and tolerability

Opioid receptor antagonists have diverse therapeutic benefits based on their respective pharmacology and sites of action; understanding their respective nuances facilitates the safe and effective use of these agents.

What Is an Opioid Antagonist?

Opioid antagonists bind to opioid receptors to block the effects of opioids. Unlike opioid agonists, they do not produce a euphoric effect or alleviate pain. However, since they still bind to the receptors, they block the space opioids would normally go.